AU1538895A - Anti-allergic vaccine - Google Patents

Anti-allergic vaccine

Info

Publication number
AU1538895A
AU1538895A AU15388/95A AU1538895A AU1538895A AU 1538895 A AU1538895 A AU 1538895A AU 15388/95 A AU15388/95 A AU 15388/95A AU 1538895 A AU1538895 A AU 1538895A AU 1538895 A AU1538895 A AU 1538895A
Authority
AU
Australia
Prior art keywords
allergic vaccine
vaccine
allergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15388/95A
Inventor
Christian Marcel Hurpin
Mireille Jeanne Marguerite Latour
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur SA
Original Assignee
Pasteur Merieux Serum et Vaccines SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Merieux Serum et Vaccines SA filed Critical Pasteur Merieux Serum et Vaccines SA
Publication of AU1538895A publication Critical patent/AU1538895A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU15388/95A 1994-01-26 1995-01-11 Anti-allergic vaccine Abandoned AU1538895A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9400846A FR2715304B1 (en) 1994-01-26 1994-01-26 Anti-allergic vaccine.
FR9400846 1994-01-26
PCT/FR1995/000034 WO1995020606A1 (en) 1994-01-26 1995-01-11 Anti-allergic vaccine

Publications (1)

Publication Number Publication Date
AU1538895A true AU1538895A (en) 1995-08-15

Family

ID=9459430

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15388/95A Abandoned AU1538895A (en) 1994-01-26 1995-01-11 Anti-allergic vaccine

Country Status (3)

Country Link
AU (1) AU1538895A (en)
FR (1) FR2715304B1 (en)
WO (1) WO1995020606A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100498198B1 (en) * 1996-03-01 2005-09-09 노파르티스 아게 Peptide Immunogen for Vaccination against and Treatment of Allergy
TW480282B (en) * 1996-04-24 2002-03-21 Ren Wen Corp Recombinant eucaryotic vector containing allergen gene and use of preventing and treating allergic disease thereof
WO1998024808A2 (en) * 1996-12-06 1998-06-11 THE UNITED STATES OF AMERICA represented by THE SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES, THE NATIONAL INSTITUTES OF HEALTH INHIBITION OF IgE-MEDIATED ALLERGIES BY A HUMAN IgE-DERIVED OLIGOPEPTIDE
US6913749B2 (en) 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
EP1621209A3 (en) * 1998-11-02 2006-04-19 Resistentia Pharmaceuticals AB Vaccines based on domains of chimeric immunoglobulin E peptides
EP2361635A3 (en) * 2000-08-30 2011-09-14 Pfizer Products Inc. Anti IgE vaccines
IL154219A0 (en) * 2000-09-06 2003-07-31 Pharmexa As Method for down-regulating ige
EP2687593A1 (en) * 2001-05-15 2014-01-22 Ortho-McNeil Pharmaceutical, Inc. Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8616166D0 (en) * 1986-07-02 1986-08-06 Research Corp Ltd Polypeptide competitor
GB8727045D0 (en) * 1987-11-19 1987-12-23 Research Corp Ltd Immunoglobulin e competitor
SE9102808L (en) * 1991-09-26 1993-03-27 Lars T Hellman Inst F Immunolo VACCIN, HOW TO USE HUMAN USE, WILL BE INTENDED TO EFFECT THE SYMPTOMS OR PREVENT THE RISE OF IGE-MEDIATED ALLERGIC REACTIONS

Also Published As

Publication number Publication date
FR2715304A1 (en) 1995-07-28
WO1995020606A1 (en) 1995-08-03
FR2715304B1 (en) 1996-04-26

Similar Documents

Publication Publication Date Title
AU4781297A (en) Vaccines
AU1308495A (en) Influenza vaccine
AU2568695A (en) Stretcher
AU2623795A (en) Immunogenic pharmaceuticals
AU3154395A (en) Contraceptive vaccine
GB9420146D0 (en) Papillomavirus vaccine
AU2769595A (en) Contraceptive vaccine
AU2308295A (en) Heterocyclylbenzonitriles
AU1538895A (en) Anti-allergic vaccine
AU2135995A (en) Pillowcase
AU1963395A (en) Boom-structure
AU4450696A (en) Enhanced immunogenic vaccine
AU3038697A (en) Meningococcal vaccine
AU3552797A (en) Vaccine preparations
AU2354895A (en) Pillow
ZA957482B (en) Vaccine
AU667183B3 (en) Stretchers
AU2937795A (en) Crutch
AU3072395A (en) Polyepitope vaccines
AU1205497A (en) Vaccine component
AU4156096A (en) Non-infective vaccines
AU7767894A (en) Nutritory induction system
AU1603595A (en) Meso-azanoradamantanes
GB9419969D0 (en) Vaccine
AU715243C (en) Acellular antibordetella vaccine